Condition: Neonatal Prematurity · Patent Ductus Arteriosus in Preterm Infants · Prostaglandins · Sponsor: Ain Shams University
prospective observational cohort study to explore the relationship between PGE2 metabolite levels and the development of hemodynamically significant PDA in preterm neonates.
This description comes directly from the study's public registry record.
Mennatallah Ayman ayman, MD student · +201004137614 · menahayman@gmail.com
Sondos Ahmed · menahayman@gmail.com
Always discuss trial participation with your own doctor first.
| Faculty of Medicine, Ain Shams, University | Cairo, Abbasia, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07338370